Keyphrases
A1 Receptor
20%
Adverse Outcomes
20%
Adverse Pregnancy Outcomes
20%
Age-matched
20%
Angiogenesis
20%
Angiogenic Factors
20%
Antiangiogenic Factors
20%
Anticoagulant Therapy
100%
Apoptosis-necrosis
20%
Capillary-like Tube Formation
20%
Circulating Levels
60%
Extracellular Domain
20%
Fetal Growth Restriction
20%
Flt-1
40%
Gestational Age
20%
Healthy Pregnant Women
20%
Heparin
100%
Heparin Anticoagulation
20%
Heparin Therapy
20%
Heparin-induced
20%
Immunoreactivity
100%
In Vitro Angiogenesis Assay
20%
Low Molecular Weight Heparin
20%
N-terminus
20%
Placental Abruption
20%
Placental Apoptosis
20%
Placental Explants
20%
Placental Growth Factor (PlGF)
20%
Preeclampsia
20%
Pregnant Women
100%
Protective Effect
20%
Protein Secretion
20%
Soluble Endoglin
20%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
100%
Third Trimester
20%
Unfractionated Heparin
20%
Vascular Endothelial Growth Factor
40%
Western Blot Analysis
20%
Medicine and Dentistry
Adverse Outcome
11%
Amino Terminal Sequence
11%
Angiogenesis
11%
Angiogenesis Assay
11%
Antiangiogenic
11%
Anticoagulant Therapy
100%
Anticoagulation
11%
Capillary
11%
Endoglin
11%
Enzyme Linked Immunosorbent Assay
11%
Fetus Growth
11%
Gestational Age
11%
Heparin
100%
Immunoreactivity
100%
In Vitro
33%
Low Molecular Weight Heparin
11%
Necrosis
11%
Placental Growth Factor
11%
Pre-Eclampsia
11%
Programmed Cell Death
11%
Protein Secretion
11%
Protein Tyrosine Kinase
100%
Third Trimester Pregnancy
11%
Upregulation
11%
Vasculotropin
22%
Vasculotropin Receptor 1
11%
Western Blot
11%
Immunology and Microbiology
Amino Terminal Sequence
20%
Angiogenesis
40%
Anticoagulation
100%
Capillary
20%
ELISA
20%
Endoglin
20%
Explant
20%
Fetus Growth
20%
Immunoreactivity
100%
Molecular Weight
20%
Placental Growth Factor
20%
Programmed Cell Death
20%
Protein Secretion
20%
Third Trimester Pregnancy
20%
Tyrosine
100%
Upregulation
20%
Vasculotropin
40%
Western Blot
20%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
22%
Anticoagulation
100%
Endoglin
11%
Explant
11%
Fetus Growth
11%
Heparin
100%
Immunoreactivity
100%
Molecular Weight
11%
N-Terminus
11%
Placental Growth Factor
11%
Programmed Cell Death
11%
Protein Secretion
11%
Soluble Fms-Like Tyrosine Kinase-1
100%
Third Trimester Pregnancy
11%
Transcription
11%
Upregulation
11%
Vascular Endothelial Growth Factor
22%
Western Blot
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
11%
Antiangiogenic
11%
Anticoagulation Therapy
100%
Endoglin
11%
Enzyme-Linked Immunosorbent Assay
11%
Heparin
100%
Low Molecular Weight Heparin
11%
Necrosis
11%
Placental Growth Factor
11%
Preeclampsia
11%
Protein Tyrosine Kinase
100%
Vasculotropin
22%
Vasculotropin Receptor 1
11%
Western Blot
11%